iPS cell transplants show early promise for treating Parkinson’s disease safely

In a first-of-its-kind human trial, researchers transplanted iPS-cell-derived dopaminergic progenitors into patients with Parkinson’s disease and observed promising motor improvements with no serious safety concerns over 24 months. The therapy…

Continue ReadingiPS cell transplants show early promise for treating Parkinson’s disease safely

Gut microbiome pattern predicts future heart attack risk in coronary heart disease patients

A specific gut microbiota pattern was found to predict new cardiovascular events in patients with coronary heart disease, based on data from the CORDIOPREV study. Researchers developed a microbiota-based risk…

Continue ReadingGut microbiome pattern predicts future heart attack risk in coronary heart disease patients